Japanese pharmaceutical company Astellas has been in the Chinese market for 30 years. The company has focused on expanding Chinese patient access to its innovative pharmaceutical products and has strengthened partnerships with local companies.
Recently, CGTN’s Wang Tianyu sat down with its chief commercial officer, Claus Zieler, to discuss pharmaceutical innovation and affordability in China’s evolving pharmaceutical landscape.